Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice
Marta Paolucci, Agathe Duda, Lara Šošić, Louise Wallace et autres
0 citationsFrontiers in Allergy
Simon Hewings
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
24Publications signalées
237Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchDermatology and Skin DiseasesContact Dermatitis and AllergiesImmunotherapy and Immune Responses
Publications récentes
Broad-Spectrum Grass Pollen Immunotherapy: Revisiting the Role of Species Diversity in Allergy Treatment
Martin Feindor, Simon Hewings, Jennifer Suzanne Goodman, Hannah Young et autres
1 citationCurrent Treatment Options in Allergy
PQ Grass 27600 SU effectively induces tolerogenic properties through modulation of humoral and cellular immune responses for the treatment of seasonal allergic rhinitis
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, Prista Hikmawati et autres
0 citationsJournal of Allergy and Clinical Immunology
Nanotechnology Based Immunotherapy With VLP Peanut Shows Strong Immuno-Modulatory Action With Benign Safety Profile In Phase I/IIA
Wayne Shreffler, Roxanne C. Oriel, Chiara Zuiani, Sviatlana Starchenka et autres
0 citationsJournal of Allergy and Clinical Immunology
Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy
Benjamin O. Slusarenko, Klara F. Borrmann, Claudia Knappe, Jonathan Vogel et autres
2 citationsJournal of Investigational Allergology and Clinical Immunology
Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, Elizabeth Palmer et autres
2 citationsAllergy
First-in-human VLP Peanut Vaccine Candidate: Safety and Tolerability Data from on-going Phase I/IIa Clinical Trial
Roxanne C. Oriel, Wayne G. Shreffler, Thomas B. Casale, Alexandra Santos et autres
4 citationsJournal of Allergy and Clinical Immunology
Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, Elizabeth Palmer et autres
11 citationsJournal of Allergy and Clinical Immunology
Title of Article: Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”
Pieter‐Jan de Kam, Stefan Zielen, Jonathan A. Bernstein, Uwe Berger et autres
0 citations
Response to Correspondence to “Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”
Pieter‐Jan de Kam, Stefan Zielen, Jonathan A. Bernstein, Uwe Berger et autres
0 citationsAllergy
Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”
Pieter‐Jan de Kam, Stefan Zielen, Jonathan A. Bernstein, Uwe Berger et autres
0 citations
Hypoallergenic Safety Profile of a Novel Virus-like Particle Vaccine for the Treatment of Peanut Allergy supported by Skin Prick Testing
Pieter‐Jan de Kam, Roxanne C. Oriel, Thomas B. Casale, Kemi Oluwayi et autres
0 citationsJournal of Allergy and Clinical Immunology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.